Stabile proteinformuleringer
SAMMENDRAG Foreliggende oppfinnelse angår generelt stabile formuleringer som omfatter CTLA4Ig-molekyler, omfattende frysetørkede og flytende formuleringer for administrering via ulike veier, som for eksempel omfatter veier så som intravenøst (IV) og subkutant (SC), for å behandle immunsystemsykdomme...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | nor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | NERURKAR MANOJ DAHLHEIM CHARLES E NARINGREKAR VIJAY H BORSADIA SUNITA GANDHI RAJESH B DALI MANISHA M |
| description | SAMMENDRAG Foreliggende oppfinnelse angår generelt stabile formuleringer som omfatter CTLA4Ig-molekyler, omfattende frysetørkede og flytende formuleringer for administrering via ulike veier, som for eksempel omfatter veier så som intravenøst (IV) og subkutant (SC), for å behandle immunsystemsykdommer og toleranseinduksjon.
The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NO20082628LL</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NO20082628LL</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NO20082628LL3</originalsourceid><addsrcrecordid>eNrjZJAJLklMysxJVSgoyi9JzcxLyy_KLc1JLcrMS08t4mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8X7-RgYGFkZmRhY-PsbEqAEA6a8kxw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Stabile proteinformuleringer</title><source>esp@cenet</source><creator>NERURKAR MANOJ ; DAHLHEIM CHARLES E ; NARINGREKAR VIJAY H ; BORSADIA SUNITA ; GANDHI RAJESH B ; DALI MANISHA M</creator><creatorcontrib>NERURKAR MANOJ ; DAHLHEIM CHARLES E ; NARINGREKAR VIJAY H ; BORSADIA SUNITA ; GANDHI RAJESH B ; DALI MANISHA M</creatorcontrib><description>SAMMENDRAG Foreliggende oppfinnelse angår generelt stabile formuleringer som omfatter CTLA4Ig-molekyler, omfattende frysetørkede og flytende formuleringer for administrering via ulike veier, som for eksempel omfatter veier så som intravenøst (IV) og subkutant (SC), for å behandle immunsystemsykdommer og toleranseinduksjon.
The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction.</description><language>nor</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080715&DB=EPODOC&CC=NO&NR=20082628L$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080715&DB=EPODOC&CC=NO&NR=20082628L$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NERURKAR MANOJ</creatorcontrib><creatorcontrib>DAHLHEIM CHARLES E</creatorcontrib><creatorcontrib>NARINGREKAR VIJAY H</creatorcontrib><creatorcontrib>BORSADIA SUNITA</creatorcontrib><creatorcontrib>GANDHI RAJESH B</creatorcontrib><creatorcontrib>DALI MANISHA M</creatorcontrib><title>Stabile proteinformuleringer</title><description>SAMMENDRAG Foreliggende oppfinnelse angår generelt stabile formuleringer som omfatter CTLA4Ig-molekyler, omfattende frysetørkede og flytende formuleringer for administrering via ulike veier, som for eksempel omfatter veier så som intravenøst (IV) og subkutant (SC), for å behandle immunsystemsykdommer og toleranseinduksjon.
The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAJLklMysxJVSgoyi9JzcxLyy_KLc1JLcrMS08t4mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8X7-RgYGFkZmRhY-PsbEqAEA6a8kxw</recordid><startdate>20080715</startdate><enddate>20080715</enddate><creator>NERURKAR MANOJ</creator><creator>DAHLHEIM CHARLES E</creator><creator>NARINGREKAR VIJAY H</creator><creator>BORSADIA SUNITA</creator><creator>GANDHI RAJESH B</creator><creator>DALI MANISHA M</creator><scope>EVB</scope></search><sort><creationdate>20080715</creationdate><title>Stabile proteinformuleringer</title><author>NERURKAR MANOJ ; DAHLHEIM CHARLES E ; NARINGREKAR VIJAY H ; BORSADIA SUNITA ; GANDHI RAJESH B ; DALI MANISHA M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NO20082628LL3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>nor</language><creationdate>2008</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>NERURKAR MANOJ</creatorcontrib><creatorcontrib>DAHLHEIM CHARLES E</creatorcontrib><creatorcontrib>NARINGREKAR VIJAY H</creatorcontrib><creatorcontrib>BORSADIA SUNITA</creatorcontrib><creatorcontrib>GANDHI RAJESH B</creatorcontrib><creatorcontrib>DALI MANISHA M</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NERURKAR MANOJ</au><au>DAHLHEIM CHARLES E</au><au>NARINGREKAR VIJAY H</au><au>BORSADIA SUNITA</au><au>GANDHI RAJESH B</au><au>DALI MANISHA M</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Stabile proteinformuleringer</title><date>2008-07-15</date><risdate>2008</risdate><abstract>SAMMENDRAG Foreliggende oppfinnelse angår generelt stabile formuleringer som omfatter CTLA4Ig-molekyler, omfattende frysetørkede og flytende formuleringer for administrering via ulike veier, som for eksempel omfatter veier så som intravenøst (IV) og subkutant (SC), for å behandle immunsystemsykdommer og toleranseinduksjon.
The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | nor |
| recordid | cdi_epo_espacenet_NO20082628LL |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | Stabile proteinformuleringer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T20%3A29%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NERURKAR%20MANOJ&rft.date=2008-07-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENO20082628LL%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |